UBS Group’s Virtus LifeSci Biotech Products ETF BBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-488
| Closed | -$28.6K | – | 8910 |
|
|
2025
Q1 | $28.6K | Buy |
488
+241
| +98% | +$14.1K | ﹤0.01% | 6681 |
|
|
2024
Q4 | $14.8K | Buy |
+247
| New | +$14.8K | ﹤0.01% | 6835 |
|
|
2024
Q1 | – | Sell |
-448
| Closed | -$26K | – | 8110 |
|
|
2023
Q4 | $26K | Buy |
+448
| New | +$26K | ﹤0.01% | 5731 |
|
|
2023
Q2 | – | Sell |
-175
| Closed | -$8.62K | – | 7814 |
|
|
2023
Q1 | $8.62K | Sell |
175
-894
| -84% | -$44.1K | ﹤0.01% | 6613 |
|
|
2022
Q4 | $52.7K | Buy |
1,069
+139
| +15% | +$6.85K | ﹤0.01% | 5578 |
|
|
2022
Q3 | $42K | Sell |
930
-614
| -40% | -$27.7K | ﹤0.01% | 5438 |
|
|
2022
Q2 | $64K | Buy |
1,544
+1,029
| +200% | +$42.7K | ﹤0.01% | 4734 |
|
|
2022
Q1 | $22K | Buy |
515
+54
| +12% | +$2.31K | ﹤0.01% | 6290 |
|
|
2021
Q4 | $23K | Buy |
461
+431
| +1,437% | +$21.5K | ﹤0.01% | 6555 |
|
|
2021
Q3 | $2K | Sell |
30
-67
| -69% | -$4.47K | ﹤0.01% | 7772 |
|
|
2021
Q2 | $5K | Sell |
97
-1,073
| -92% | -$55.3K | ﹤0.01% | 7423 |
|
|
2021
Q1 | $61K | Sell |
1,170
-1,222
| -51% | -$63.7K | ﹤0.01% | 5353 |
|
|
2020
Q4 | $127K | Buy |
2,392
+882
| +58% | +$46.8K | ﹤0.01% | 4553 |
|
|
2020
Q3 | $72K | Sell |
1,510
-615
| -29% | -$29.3K | ﹤0.01% | 4556 |
|
|
2020
Q2 | $101K | Buy |
2,125
+446
| +27% | +$21.2K | ﹤0.01% | 4475 |
|
|
2020
Q1 | $63K | Buy |
1,679
+233
| +16% | +$8.74K | ﹤0.01% | 4758 |
|
|
2019
Q4 | $63K | Sell |
1,446
-1,764
| -55% | -$76.9K | ﹤0.01% | 5183 |
|
|
2019
Q3 | $115K | Buy |
3,210
+1,112
| +53% | +$39.8K | ﹤0.01% | 4769 |
|
|
2019
Q2 | $86K | Buy |
2,098
+2,024
| +2,735% | +$83K | ﹤0.01% | 4638 |
|
|
2019
Q1 | $3K | Sell |
74
-1,163
| -94% | -$47.1K | ﹤0.01% | 6485 |
|
|
2018
Q4 | $43K | Sell |
1,237
-617
| -33% | -$21.4K | ﹤0.01% | 5322 |
|
|
2018
Q3 | $84K | Buy |
1,854
+769
| +71% | +$34.8K | ﹤0.01% | 4857 |
|
|
2018
Q2 | $48K | Buy |
1,085
+55
| +5% | +$2.43K | ﹤0.01% | 5087 |
|
|
2018
Q1 | $43K | Sell |
1,030
-547
| -35% | -$22.8K | ﹤0.01% | 4974 |
|
|
2017
Q4 | $64K | Buy |
1,577
+1,542
| +4,406% | +$62.6K | ﹤0.01% | 4717 |
|
|
2017
Q3 | $1K | Sell |
35
-57
| -62% | -$1.63K | ﹤0.01% | 6630 |
|
|
2017
Q2 | $4K | Sell |
92
-2,290
| -96% | -$99.6K | ﹤0.01% | 6245 |
|
|
2017
Q1 | $90K | Sell |
2,382
-1,505
| -39% | -$56.9K | ﹤0.01% | 4258 |
|
|
2016
Q4 | $127K | Buy |
+3,887
| New | +$127K | ﹤0.01% | 4249 |
|
|
2016
Q3 | – | Sell |
-1,538
| Closed | -$41K | – | 6691 |
|
|
2016
Q2 | $41K | Buy |
+1,538
| New | +$41K | ﹤0.01% | 4805 |
|
|
2016
Q1 | – | Sell |
-1,213
| Closed | -$37K | – | 6691 |
|
|
2015
Q4 | $37K | Sell |
1,213
-218
| -15% | -$6.65K | ﹤0.01% | 5000 |
|
|
2015
Q3 | $40K | Buy |
1,431
+273
| +24% | +$7.63K | ﹤0.01% | 4876 |
|
|
2015
Q2 | $41K | Sell |
1,158
-21
| -2% | -$744 | ﹤0.01% | 4907 |
|
|
2015
Q1 | $37K | Buy |
+1,179
| New | +$37K | ﹤0.01% | 4880 |
|